Charlie Garnett-Benson

7PUBLICATIONS
43CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 07, 2026
Leukemic fusion genes repress viral gene expression and expel adenovirus from persistently infected human B lymphocytes but evidence of the virus lingers behind.

H T Wilms, D A Ornelles, L R Gooding

|Jul 03, 2025
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.

Evan J Lipson, Sonia Dolfi, Hao Tang

|Jun 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy.

Ryan J Sullivan, Anthony R Cillo, Robert L Ferris

|Feb 26, 2025
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020.

Paolo A Ascierto, Hao Tang, Sonia Dolfi

|Jan 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.

Shailender Bhatia, Suzanne L Topalian, William Sharfman

|Jul 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.

Anne Monette, Sarah Warren, J Carl Barrett

Pageof 2

Frequent Collaborators

3 joint publications

Evan J Lipson

2 joint publications

Kurt A Schalper

2 joint publications

Paolo A Ascierto

2 joint publications

Robert L Ferris